Browse our extensive catalog of high-quality chemicals for research and development.
| Product Name | Description | CAS Number | Molecular Formula | Molecular Weight | Description |
|---|---|---|---|---|---|
| N-(L-Valyl) Valganciclovir Hydrochloride | L-Valyl-L-valine 2-[(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3- hydroxypropyl Ester Hydrochloride; | C19H32ClN7O6 | 489.95 | L-Valyl-L-valine 2-[(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3- hydroxypropyl Ester Hydrochloride;
| |
| [[(1alpha,3beta,6S,7E,22E)-6,19-Sulfonyl-9,10-secoergosta-5(10),7,22-triene-1,3-diyl]bis(oxy)]bis[(1,1-dimethylethyl)dimethyl-silane | (1S,​4S,​6R)​-4,​6-​Bis[[(1,​1-​dimethylethyl)​dimethylsilyl]​oxy]​-​1,​3,​4,​5,​6,​7-​hexahydro-​1-​[(E)​-​[(1R,​3aS,​7aR)​-​octahydro-​7a-​methyl-​1-​[(1R,​2E,​4R)​-​1,​4,​5-​trimethyl-​2-​hexen-​1-​yl]​-​4H-​inden-​4-​ylidene]​methyl]​-benzo[c]​thiophene 2,​2-​dioxide | 112670-79-8 | C40H72O4SSi2 | 705.23 | (1S,​4S,​6R)​-4,​6-​Bis[[(1,​1-​dimethylethyl)​dimethylsilyl]​oxy]​-​1,​3,​4,​5,​6,​7-​hexahydro-​1-​[(E)​-​... |
| GSK 321 | (R)-1-(4-Fluorobenzyl)-N-(3-((S)-1-hydroxyethyl)phenyl)-7-methyl-5-(1H-pyrrole-2-carbonyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine-3-carboxamide | 1816331-63-1 | C28H28FN5O3 | 501.55 | (R)-1-(4-Fluorobenzyl)-N-(3-((S)-1-hydroxyethyl)phenyl)-7-methyl-5-(1H-pyrrole-2-carbonyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine-3-carboxamide... |
| (R)-Sulindac Methyl Ester | (1Z)-5-Fluoro-2-methyl-1-[[4-[(R)-methylsulfinyl]phenyl]methylene]-1H-indene-3-acetic Acid Methyl Ester | 929081-61-8 | C21H19FO3S | 370.44 | (1Z)-5-Fluoro-2-methyl-1-[[4-[(R)-methylsulfinyl]phenyl]methylene]-1H-indene-3-acetic Acid Methyl Ester
|
| L-Valyl-L-histidine | N-L-Valyl-L-histidine; 139: PN: WO2012013136 SEQID: 184 Claimed Protein; 153: PN: WO2011146121 PAGE: 116 Claimed Sequence; 31: PN: EP2161028 PAGE: 10 Claimed Protein; 8: PN: WO03052099 PAGE: 83 Claimed Protein; L-Valyl-L-histidine; Valylhistidine | 13589-07-6 | Câ‚â‚11₈N4O3 | 254.29 | N-L-Valyl-L-histidine; 139: PN: WO2012013136 SEQID: 184 Claimed Protein; 153: PN: WO2011146121 PAGE: 116 Claimed Sequence; 31: PN: EP2161028 PAGE: 10 ... |
| GSK 2018682 | 4-[5-[5-Chloro-6-(1-methylethoxy)-3-pyridinyl]-1,2,4-oxadiazol-3-yl]-1H-indole-1-butanoic Acid | 1034688-30-6 | C22H21ClN4O4 | 440.88 | 4-[5-[5-Chloro-6-(1-methylethoxy)-3-pyridinyl]-1,2,4-oxadiazol-3-yl]-1H-indole-1-butanoic Acid
|
| N-(2-Sulfanylphenyl) Vortioxetine | N-(2-((2,4-Dimethylphenyl)thio)phenyl)-N-(2-mercaptophenyl)piperazine | C24H26N2S2 | 406.61 | N-(2-((2,4-Dimethylphenyl)thio)phenyl)-N-(2-mercaptophenyl)piperazine
| |
| (3-Amino-1-piperidinyl)[2-(1-ethyl-1H-indol-2-yl)-1-methyl-1H-benzimidazol-6-yl]-methanone Hydrochloride | 1652591-82-6 | C24H28ClN5O | 437.97 | ||
| 5-(2-Sulfanylidene-3H-1,3-thiazol-4-yl)thiophene-2-carboxamide | 5-(2,3-Dihydro-2-thioxo-4-thiazolyl)-2-thiophenecarboxamide; NSC 317939 | 52560-89-1 | C8H6N2OS3 | 242.34 | 5-(2,3-Dihydro-2-thioxo-4-thiazolyl)-2-thiophenecarboxamide; NSC 317939
|
| L-Valyl-L-histidyl-L-leucyl-L-threonyl-L-prolyl-L-glutamic Acid Trifluoroacetate | N-[1-[N-[N-(N-Valylhistidyl)leucyl]threonyl]prolyl]-glutamic Acid Trifluoroacetate; 1: PN: WO2010067611 SEQID: 1 Claimed Protein; 1: PN: WO2010067612 SEQID: 1 Unclaimed Protein; 9: PN: WO2011072833 SEQID: 3 Claimed Protein | 93913-39-4 | C31H50N8O10 xC2HFO2 | 694.78 | N-[1-[N-[N-(N-Valylhistidyl)leucyl]threonyl]prolyl]-glutamic Acid Trifluoroacetate; 1: PN: WO2010067611 SEQID: 1 Claimed Protein; 1: PN: WO2010067612 ... |
Page 5215 of 10017